The human ovarian carcinoma SK-OV-3/A2780 cell line is able to convert in vitro CD8+ T cells into a CD8+ Treg phenotype that promotes tumor progression through immune regulation partially mediated by TGF-β1 and IFN-γ (170). This evidence concerns the gene CD8A and neoplasm.